Almirall is a global biopharmaceutical company focused on medical dermatology. Founded in 1944 and with headquarters in Barcelona (Spain), our purpose is at the core of our work: “Transform the patients’ world by helping them realize their hopes and dreams for a healthy life”. Through pharmaceutical innovation, investment in R&D and strong commitment to global healthcare partnerships, we develop and commercialize solutions with specific focus on dermatological diseases such as psoriasis, actinic keratosis, atopic dermatitis or acne. We care and listen to our patients’ needs. We find solutions for them. We aim to empower them. Almirall has 1 R&D center, 2 chemical plants and 2 pharmaceutical plants. Our more than 1,900 employees make it possible for our treatments to be available in over 100 countries across 5 continents, through our 15 global affiliates and via a strategic partnership network. Almirall is listed on the Spanish Stock Exchange (ticker: ALM).
Unlock the market timeline & signal feed
39 signals in the last 90 days.
The order this company entered each market — oldest to newest
14 active postings
Facharztaußendienst Dermatologie (Biologika) (m/w/d), Region L1: Dresden, Cottbus, Görlitz, Wittenberg
Sign up to see the full signal feed
How Almirall's international expansion compares to its competitors
AlmirallYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 AlmirallYou | 3 | 0 | +38% | 38 | 30 |
Product Manager (m/w/d) Atopic Dermatitis (AD)
View postingHamburg, Hamburg, Germany · 3d ago
MEDICAL AFFAIRS SENIOR MANAGER Temporary
View postingBarcelona, Catalonia, Spain · 4d ago
IT BUSINESS PROCESS MANAGER
View postingSant Andreu de la Barca, Catalonia, Spain · 6d ago
At Almirall, our "Act4Impact" strategy is the blueprint that integrates five vital pillars into our daily operations. This framework ensures our growth in medical dermatology is as responsible as it is innovative. Our commitment to a positive legacy includes: - Planet: A science-led roadmap toward Net Zero emissions. -People: Fostering a diverse and inclusive culture where our teams lead with integrity. - Patients: Placing people living with skin conditions at the core of every decision. - Part ...
EndedFor those living with chronic skin conditions, physical symptoms are only one part of the journey. Psychological distress, social isolation, and sleep disturbances can persist even after skin clearance. At Almirall, we aim to lead a paradigm shift. By integrating the WHO-5 Well-being Index into our clinical trials, we demonstrate our commitment to placing patient wellbeing at the heart of everything we do. Our goal is to transform the patient's world - addressing the person that lives behind the ...
EndedFor those living with chronic skin conditions, physical symptoms are only one part of the journey. Psychological distress, social isolation, and sleep disturbances can persist even after skin clearance. At Almirall, we aim to lead a paradigm shift. By integrating the WHO-5 Well-being Index into our clinical trials, we demonstrate our commitment to placing patient wellbeing at the heart of everything we do. Our goal is to transform the patient's world - addressing the person that lives behind the ...
EndedAlmirall's shareholders re-elected Carlos Gallardo as CEO and Enrique de Leyva as Vice President. The company will distribute a flexible dividend of 0.19 euros per share.
Almirall's shareholders re-elected Carlos Gallardo as President and CEO, approved flexible dividend of €0.19 per share.
Qualifyze introduces Quality Insights Platform, an AI-powered tool for pharmaceutical risk management, leveraging the world's largest audit database.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Almirall's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
